{"id":5492,"date":"2021-06-28T11:08:12","date_gmt":"2021-06-28T11:08:12","guid":{"rendered":"https:\/\/www.adacyte.com\/?post_type=scientific-corner&#038;p=5492"},"modified":"2024-05-02T09:48:24","modified_gmt":"2024-05-02T07:48:24","slug":"use-of-granulocyte-monocytapheresis-in-ulcerative-colitis-a-practical-review-from-a-european-perspective","status":"publish","type":"scientific-corner","link":"https:\/\/www.adacyte.com\/fr\/professional\/scientific-corner\/use-of-granulocyte-monocytapheresis-in-ulcerative-colitis-a-practical-review-from-a-european-perspective\/","title":{"rendered":"Use of granulocyte\/monocytapheresis in ulcerative colitis: A practical review from a European perspective"},"content":{"rendered":"<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=Dom%26%23x000e8%3Bnech%20E%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=33776362\">Eugeni Dom\u00e8nech<\/a>,&nbsp;<a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=Gr%26%23x000ed%3Bfols%20JR%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=33776362\">Joan-Ramon Gr\u00edfols<\/a>,&nbsp;<a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=Akbar%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=33776362\">Ayesha Akbar<\/a>, and&nbsp;<a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=Dignass%20AU%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=33776362\">Axel U Dignass<\/a> <a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC7968132\/#\">World J Gastroenterol.<\/a>&nbsp;2021 Mar 14; 27(10): 908\u2013918.<\/p>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p>GMA is the only available therapy for UC directly targeting neutrophils. Two controlled, multicentre, European studies and a number of recent cases series found a potential therapeutic benefit of GMA in different clinical scenarios of UC with a still unmet need for optimal treatment. Moreover, GMA has an excellent safety profile and is perceived as a convenient procedure by patients, making this non-pharmacological therapy a suitable alternative or add-on therapy in UC, particularly for frail or comorbid patients.<\/p>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC7968132\/\">https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC7968132\/<\/a><\/p>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC7968132\/pdf\/WJG-27-908.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC7968132\/pdf\/WJG-27-908.pdf<\/a><\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>Eugeni Dom\u00e8nech,&nbsp;Joan-Ramon Gr\u00edfols,&nbsp;Ayesha Akbar, and&nbsp;Axel U Dignass World J Gastroenterol.&nbsp;2021 Mar 14; 27(10): 908\u2013918. GMA is the only available therapy for UC directly targeting neutrophils. Two controlled, multicentre, European studies and a number of recent cases series found a potential therapeutic benefit of GMA in different clinical scenarios of UC with a still unmet need [&hellip;]<\/p>\n","protected":false},"template":"","scientific_tags":[303,440,439,157,441,442,64,321,424,437,366,156,306],"class_list":["post-5492","scientific-corner","type-scientific-corner","status-publish","hentry","scientific_tags-combination","scientific_tags-comorbidity","scientific_tags-convenience","scientific_tags-efficacy","scientific_tags-euroep","scientific_tags-europe","scientific_tags-frail","scientific_tags-gastroenterology","scientific_tags-gma","scientific_tags-monotherapy","scientific_tags-neutrophil-infiltration","scientific_tags-safety","scientific_tags-ulcerative-colitis"],"acf":{"sc_authors":"<a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC7968132\/\">https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC7968132\/<\/a>\r\n\r\n<a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC7968132\/pdf\/WJG-27-908.pdf\">https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC7968132\/pdf\/WJG-27-908.pdf<\/a>"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Use of granulocyte\/monocytapheresis in ulcerative colitis: A practical review from a European perspective - Adacyte<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/use-of-granulocyte-monocytapheresis-in-ulcerative-colitis-a-practical-review-from-a-european-perspective\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Use of granulocyte\/monocytapheresis in ulcerative colitis: A practical review from a European perspective - Adacyte\" \/>\n<meta property=\"og:description\" content=\"Eugeni Dom\u00e8nech,&nbsp;Joan-Ramon Gr\u00edfols,&nbsp;Ayesha Akbar, and&nbsp;Axel U Dignass World J Gastroenterol.&nbsp;2021 Mar 14; 27(10): 908\u2013918. GMA is the only available therapy for UC directly targeting neutrophils. Two controlled, multicentre, European studies and a number of recent cases series found a potential therapeutic benefit of GMA in different clinical scenarios of UC with a still unmet need [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/use-of-granulocyte-monocytapheresis-in-ulcerative-colitis-a-practical-review-from-a-european-perspective\/\" \/>\n<meta property=\"og:site_name\" content=\"Adacyte\" \/>\n<meta property=\"article:modified_time\" content=\"2024-05-02T07:48:24+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/use-of-granulocyte-monocytapheresis-in-ulcerative-colitis-a-practical-review-from-a-european-perspective\/\",\"url\":\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/use-of-granulocyte-monocytapheresis-in-ulcerative-colitis-a-practical-review-from-a-european-perspective\/\",\"name\":\"Use of granulocyte\/monocytapheresis in ulcerative colitis: A practical review from a European perspective - Adacyte\",\"isPartOf\":{\"@id\":\"https:\/\/www.adacyte.com\/#website\"},\"datePublished\":\"2021-06-28T11:08:12+00:00\",\"dateModified\":\"2024-05-02T07:48:24+00:00\",\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/use-of-granulocyte-monocytapheresis-in-ulcerative-colitis-a-practical-review-from-a-european-perspective\/\"]}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.adacyte.com\/#website\",\"url\":\"https:\/\/www.adacyte.com\/\",\"name\":\"Adacyte\",\"description\":\"Adacyte Therapeutics\",\"publisher\":{\"@id\":\"https:\/\/www.adacyte.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.adacyte.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.adacyte.com\/#organization\",\"name\":\"Adacyte\",\"url\":\"https:\/\/www.adacyte.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg\",\"contentUrl\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg\",\"width\":165,\"height\":46,\"caption\":\"Adacyte\"},\"image\":{\"@id\":\"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Use of granulocyte\/monocytapheresis in ulcerative colitis: A practical review from a European perspective - Adacyte","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/use-of-granulocyte-monocytapheresis-in-ulcerative-colitis-a-practical-review-from-a-european-perspective\/","og_locale":"fr_FR","og_type":"article","og_title":"Use of granulocyte\/monocytapheresis in ulcerative colitis: A practical review from a European perspective - Adacyte","og_description":"Eugeni Dom\u00e8nech,&nbsp;Joan-Ramon Gr\u00edfols,&nbsp;Ayesha Akbar, and&nbsp;Axel U Dignass World J Gastroenterol.&nbsp;2021 Mar 14; 27(10): 908\u2013918. GMA is the only available therapy for UC directly targeting neutrophils. Two controlled, multicentre, European studies and a number of recent cases series found a potential therapeutic benefit of GMA in different clinical scenarios of UC with a still unmet need [&hellip;]","og_url":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/use-of-granulocyte-monocytapheresis-in-ulcerative-colitis-a-practical-review-from-a-european-perspective\/","og_site_name":"Adacyte","article_modified_time":"2024-05-02T07:48:24+00:00","twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/use-of-granulocyte-monocytapheresis-in-ulcerative-colitis-a-practical-review-from-a-european-perspective\/","url":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/use-of-granulocyte-monocytapheresis-in-ulcerative-colitis-a-practical-review-from-a-european-perspective\/","name":"Use of granulocyte\/monocytapheresis in ulcerative colitis: A practical review from a European perspective - Adacyte","isPartOf":{"@id":"https:\/\/www.adacyte.com\/#website"},"datePublished":"2021-06-28T11:08:12+00:00","dateModified":"2024-05-02T07:48:24+00:00","inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.adacyte.com\/professional\/scientific-corner\/use-of-granulocyte-monocytapheresis-in-ulcerative-colitis-a-practical-review-from-a-european-perspective\/"]}]},{"@type":"WebSite","@id":"https:\/\/www.adacyte.com\/#website","url":"https:\/\/www.adacyte.com\/","name":"Adacyte","description":"Adacyte Therapeutics","publisher":{"@id":"https:\/\/www.adacyte.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.adacyte.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.adacyte.com\/#organization","name":"Adacyte","url":"https:\/\/www.adacyte.com\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg","contentUrl":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg","width":165,"height":46,"caption":"Adacyte"},"image":{"@id":"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.adacyte.com\/fr\/wp-json\/wp\/v2\/scientific-corner\/5492","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.adacyte.com\/fr\/wp-json\/wp\/v2\/scientific-corner"}],"about":[{"href":"https:\/\/www.adacyte.com\/fr\/wp-json\/wp\/v2\/types\/scientific-corner"}],"wp:attachment":[{"href":"https:\/\/www.adacyte.com\/fr\/wp-json\/wp\/v2\/media?parent=5492"}],"wp:term":[{"taxonomy":"scientific_tags","embeddable":true,"href":"https:\/\/www.adacyte.com\/fr\/wp-json\/wp\/v2\/scientific_tags?post=5492"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}